Previous prospective studies of individual or small panels of blood proteins have identified aetiological cancer proteins, such as insulin-like growth factor-I, which is a causal risk factor for breast, colorectal, and prostate cancers, and microseminoprotein-beta, which is associated with lower prostate cancer risk1–3. This evidence concerns the gene MSMB and prostate cancer.